Please Wait

Applying Filters...

Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

ACID YELLOW 73

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 8 USDMF, 1 CEP/COS, 3 NDC API, 9 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 2 FDA Orange Book, 15 Europe, 2 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - 0.4%;0.25%, SOLUTION/DROPS;OPHTHALMIC - 0.4%;0.3%

RELATED EXCIPIENT COMPANIES

1 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 1 Actylis, 1 Ashland, 9 BASF, 1 Gangwal Chemicals, 1 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Pluviaendo

EXCIPIENTS BY APPLICATIONS

7 Fillers, Diluents & Binders, 6 Solubilizers, 5 Granulation, 3 Parenteral, 3 Controlled & Modified Release, 3 Direct Compression, 1 Disintegrants & Superdisintegrants, 1 Thickeners and Stabilizers, 1 Topical, 1 Film Formers & Plasticizers, 1 Coating Systems & Additives